In a trial before Judge Wilson in the United States District Court in Little Rock, Arkansas, a jury has added on to a compensatory damage award of 2.7 Million dolars, with $26 Million Dollars in punitive damages against Wyeth and Pfizer, who manufactured and marketed two compenents of a common combination of hormone replacement therapy used in menopausal women. Wyeth manufactures premarin (containing estrogen) and Prempro (a combination of estrogen and progesterone) and Pfizer manufactured Provera, which contained progesterone. A study published in July of 2002, pointed to clear link between hormone replacement and breast cancer. This link has been documented in multiple epidemiological studies published since 2002.
The justice attorneys of Aylstock, Witkin, Kreis & Overholtz have been actively accepting Prempro breast cancer cases where it can be shown that the cancer is hormone sensitive breast cancer. If you would like more information about hormone replacement breast cancer litigation, please visit the hormone therapy lawyer website or the hormone replacement breast cancer defective drug website.